Certara Inc
NASDAQ:CERT

  • LAST PRICE
    11.2100
  • TODAY'S CHANGE (%)
    -0.0600 (-0.5324%)
  • Bid / Lots
    10.7500/ 3
  • Ask / Lots
    11.6000/ 1
  • Open / Previous Close
    11.2600 / 11.2700
  • Day Range
    11.1000
    11.3400
  • 52 Week Range
    9.4100
    19.8702
  • Volume
    497,170

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Software Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
CERT
Certara Inc
1.8B
-57.7x
---
SPT
Sprout Social Inc
1.8B
-26.8x
---
OPRA
Opera Ltd
1.8B
10.1x
+38.75%
PHR
Phreesia Inc
1.2B
-11.8x
---
SEMR
SEMrush Holdings Inc
2.0B
177.6x
---
NABL
N-Able Inc
1.9B
52.9x
---
As of 2024-11-30

Company Information

Certara, Inc. is engaged in model-informed drug development. The Company accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to efficiently carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services are underpinned by technologies such as regulatory submissions software, natural language processing and Bayesian analytics. It also develops scientific informatics software products used by the life sciences industry for in-silico research. It develops advanced modeling and biosimulation solutions used to predict the pharmacokinetic and pharmacodynamic properties. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 66 countries.

Contact Information

Headquarters
4 Radnor Corporate Center, Suite 350RADNOR, PA, United States 19087
Phone
415-237-8272
Fax
302-636-5454

Executives

Independent Chairman of the Board
James Cashman
President, Chief Commercial Officer
Leif Pedersen
Chief Executive Officer, Director
William Feehery
Chief Financial Officer, Senior Vice President
John Gallagher
President - Certara Scientific Software
Robert Aspbury

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$1.8B
Revenue (TTM)
$372.8M
Shares Outstanding
161.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.53
EPS
$-0.19
Book Value
$6.55
P/E Ratio
-57.7x
Price/Sales (TTM)
4.7
Price/Cash Flow (TTM)
52.4x
Operating Margin
-4.35%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.